Therefore, based on the facts, we hypothesized that TRF treatment may attenuate the AlCl3-induced neurovascular dysfunction-associated VaD in rats, perhaps by reducing oxidative stress, SVD, ED, and facilitating the neovascularisation process by activating PDGF-C. This evidence concerns the gene PDGFC and snowflake vitreoretinal degeneration.